These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30408585)

  • 1. Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study.
    Mirouse A; Seror R; Vicaut E; Mariette X; Dougados M; Fauchais AL; Deroux A; Dellal A; Costedoat-Chalumeau N; Denis G; Sellam J; Arlet JB; Lavigne C; Urbanski G; Fischer-Dumont D; Diallo A; Fain O; Mékinian A;
    Autoimmun Rev; 2019 Jan; 18(1):9-14. PubMed ID: 30408585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing hand and wrist ultrasound pattern in primary Sjögren's syndrome: a case-control study.
    Guedes LKN; Leon EP; Bocate TS; Bonfigliolli KR; Lourenço SV; Bonfa E; Pasoto SG
    Clin Rheumatol; 2020 Jun; 39(6):1907-1918. PubMed ID: 32072351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
    Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
    Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint involvement in primary Sjögren's syndrome: an ultrasound "target area approach to arthritis".
    Amezcua-Guerra LM; Hofmann F; Vargas A; Rodriguez-Henriquez P; Solano C; Hernández-Díaz C; Castillo-Martinez D; Ventura-Ríos L; Gutiérrez M; Pineda C
    Biomed Res Int; 2013; 2013():640265. PubMed ID: 23936829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
    Carubbi F; Cipriani P; Marrelli A; Benedetto P; Ruscitti P; Berardicurti O; Pantano I; Liakouli V; Alvaro S; Alunno A; Manzo A; Ciccia F; Gerli R; Triolo G; Giacomelli R
    Arthritis Res Ther; 2013 Oct; 15(5):R172. PubMed ID: 24286296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ; Kelder JC
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y; Wang YF; Wang KL; Lv FF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.
    Atzeni F; Sarzi-Puttini P; Lama N; Bonacci E; Bobbio-Pallavicini F; Montecucco C; Caporali R
    Arthritis Res Ther; 2008; 10(3):R51. PubMed ID: 18462485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
    Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature.
    Launay D; Hachulla E; Hatron PY; Jais X; Simonneau G; Humbert M
    Medicine (Baltimore); 2007 Sep; 86(5):299-315. PubMed ID: 17873760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-citrullinated protein antibodies and arthritis in Sjögren's syndrome: a systematic review and meta-analysis.
    Molano-González N; Olivares-Martínez E; Anaya JM; Hernández-Molina G
    Scand J Rheumatol; 2019 Mar; 48(2):157-163. PubMed ID: 30270696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.
    Delli K; Haacke EA; Kroese FG; Pollard RP; Ihrler S; van der Vegt B; Vissink A; Bootsma H; Spijkervet FK
    Ann Rheum Dis; 2016 Nov; 75(11):1933-1938. PubMed ID: 26757748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients.
    Bai W; Yang F; Xu H; Wei W; Li H; Zhang L; Zhao Y; Shi X; Zhang Y; Zeng X; Leng X
    Trials; 2023 Feb; 24(1):112. PubMed ID: 36793118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of primary Sjogren's syndrome patients presenting positive anti-cyclic citrullinated peptides antibody.
    Ryu YS; Park SH; Lee J; Kwok SK; Ju JH; Kim HY; Jeon CH
    Rheumatol Int; 2013 Jun; 33(6):1443-6. PubMed ID: 23179261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjögren syndrome.
    Kim SM; Park E; Lee JH; Lee SH; Kim HR
    Rheumatol Int; 2012 Dec; 32(12):3963-7. PubMed ID: 22205381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
    Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remitting seronegative symmetrical synovitis with pitting edema and primary Sjögren's syndrome.
    Fietta P; Manganelli P
    Clin Exp Rheumatol; 2000; 18(2):269-70. PubMed ID: 10812512
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations.
    Haga HJ; Andersen DT; Peen E
    Clin Rheumatol; 2011 Mar; 30(3):369-72. PubMed ID: 21234630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The findings of musculoskeletal ultrasonography on primary Sjögren's syndrome patients in childhood with articular manifestations and the impact of anti-cyclic citrullinated peptide antibody.
    Shabana K; Okamoto N; Sugita Y; Shindo K; Murata T; Tamai H; Fujiwara K
    Mod Rheumatol; 2019 Sep; 29(5):821-828. PubMed ID: 30289018
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.